¿ªÔÆÌåÓý

Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the Vaccine Safety Datalink, 2022-2023. 

Human Vaccines & Immunotherapeutics. 2025

Attitudes toward COVID-19 vaccines among pregnant and recently pregnant individuals. 

JAMA network open. 2024

Coronavirus disease 2019 (COVID-19) vaccination and stillbirth in the Vaccine Safety Datalink. 

Obstetrics and Gynecology. 2024

Impact of the COVID-19 pandemic on health care utilization in the Vaccine Safety Datalink: retrospective cohort study. 

JMIR public health and surveillance. 2024

Influenza vaccination accuracy among adults: self-report compared with electronic health record data. 

Vaccine. 2024

Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection. 

Nature communications. 2024

Safety of the seasonal influenza vaccine in 2 successive pregnancies. 

JAMA network open. 2024

Tinnitus after COVID-19 vaccination: findings from the vaccine adverse event reporting system and the vaccine safety datalink. 

American Journal of Otolaryngology. 2024

A broad assessment of COVID-19 vaccine safety using tree-based data-mining in the vaccine safety datalink. 

Vaccine. 2023

Active postlicensure safety surveillance for recombinant zoster vaccine using electronic health record data. 

American Journal of Epidemiology. 2023

COVID-19 booster vaccination in early pregnancy and surveillance for spontaneous abortion. 

JAMA network open. 2023

COVID-19 vaccine safety surveillance in early pregnancy in the United States: design factors affecting the association between vaccine and spontaneous abortion. 

American Journal of Epidemiology. 2023

Medically attended acute adverse events in pregnant people after coronavirus disease 2019 (COVID-19) booster vaccination. 

Obstetrics and Gynecology. 2023

Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: the contribution of vaccine-related attitudes. 

Preventive Medicine. 2023

Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink. 

Vaccine. 2023

Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink. 

Vaccine. 2023

Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. 

Vaccine. 2022

Evaluation of acute adverse events after Covid-19 vaccination during pregnancy. 

New England Journal of Medicine. 2022

Health care utilization in the 6 months following SARS-CoV-2 infection. 

JAMA network open. 2022

Incidence of Guillain-Barré syndrome after COVID-19 vaccination in the Vaccine Safety Datalink. 

JAMA network open. 2022

Kawasaki disease following the 13-valent pneumococcal conjugate vaccine and rotavirus vaccines. 

Pediatrics. 2022

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. 

Vaccine. 2022

Safety of COVID-19 vaccination in United States children ages 5 to 11 years. 

Pediatrics. 2022

COVID-19 vaccination coverage among insured persons aged â‰�16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021. 

MMWR: Morbidity and Mortality Weekly Report. 2021

COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. 

MMWR: Morbidity and Mortality Weekly Report. 2021

Surveillance for adverse events after COVID-19 mRNA vaccination. 

JAMA. 2021

Challenges involved in establishing a web-based clinical decision support tool in community health centers. 

Healthcare (Amsterdam, Netherlands). 2020

Evaluating the association of stillbirths after maternal vaccination in the Vaccine Safety Datalink. 

Obstetrics and Gynecology. 2020

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. 

Pharmacoepidemiology and Drug Safety. 2018

Development and validation of a method to identify children with social complexity risk factors. 

Pediatrics. 2016

Safety of measles-containing vaccines in 1-year-old children. 

Pediatrics. 2015

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. 

Vaccine. 2014

Timely versus delayed early childhood vaccination and seizures. 

Pediatrics. 2014

A population-based cohort study of undervaccination in 8 managed care organizations across the United States. 

JAMA pediatrics. 2013

Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. 

JAMA pediatrics. 2013

Vaccination site and risk of local reactions in children 1 through 6 years of age. 

Pediatrics. 2013

Injection site and risk of medically attended local reactions to acellular pertussis vaccine. 

Pediatrics. 2011

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. 

BMC Infectious Diseases. 2009

Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. 

Vaccine. 2009